Literature DB >> 2309452

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

P A Rota1, T R Wallis, M W Harmon, J S Rota, A P Kendal, K Nerome.   

Abstract

During 1988-1989 two highly distinct antigenic variants of influenza type B were recognized in hemagglutination-inhibition tests with postinfection ferret serum. These viruses were antigenically related to either B/Victoria/2/87, the most recent reference strain, or B/Yamagata/16/88, a variant that was isolated in Japan in May 1988. All influenza B viruses isolated in the United States during an epidemic in the winter of 1988-1989 were antigenically related to B/Victoria/2/87. However, in several countries in Asia, both B/Victoria/2/87-like viruses and B/Yamagata/16/88-like viruses were isolated. Sequence analysis of the hemagglutinin (HA) genes of several influenza B isolates from 1987 to 1988 indicated that the HA1 domains of the B/Yamagata/16/88-like viruses and B/VI/87-like viruses isolated in 1988 differed by 27 amino acids. Evolutionary relationships based on this sequence data indicated that the B/Yamagata/16/88-like viruses were more closely related to epidemic viruses from 1983 (B/USSR/100/83-like viruses) than to more recent reference strains such as B/Victoria/2/87. All other Asian strains, as well as selected isolates from the United States in 1988, were confirmed by sequence analysis as being genetically related to B/Victoria/2/87. These data provide clear evidence that two parallel evolutionary pathways of influenza type B have existed since at least 1983 and that viruses from each of the separate lineages were isolated from cases of influenza B in 1988. This finding is similar to earlier observations for type A H1N1 and H3N2 influenza viruses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309452     DOI: 10.1016/0042-6822(90)90186-u

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  216 in total

1.  Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature.

Authors:  J A McCullers; G C Wang; S He; R G Webster
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

3.  Evolution of surface and nonstructural-1 genes of influenza B viruses isolated in the Province of Québec, Canada, during the 1998-2001 period.

Authors:  Yacine Abed; Michael B Coulthart; Yan Li; Guy Boivin
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

5.  Influenza Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

6.  Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010.

Authors:  Yi Tan; Wenda Guan; Tommy Tsan-Yuk Lam; Sihua Pan; Shiguan Wu; Yangqing Zhan; Cecile Viboud; Edward C Holmes; Zifeng Yang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

7.  Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.

Authors:  Kara L Phipps; Nicolle Marshall; Hui Tao; Shamika Danzy; Nina Onuoha; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 8.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

9.  Rescue of influenza B virus from eight plasmids.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Chin-Fen Yang; Robert G Webster; Harry B Greenberg; George Kemble
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

Review 10.  Broadly neutralizing antibodies against influenza viruses.

Authors:  Nick S Laursen; Ian A Wilson
Journal:  Antiviral Res       Date:  2013-04-09       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.